Clinical Trial Update: A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating Faropenem medoxomil for acute otitis media.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Faropenem medoxomil (faropenem medoxomil)

Snippet

Sponsor: Replidyne | Conditions: Otitis Media | Phase 2 | Status: COMPLETED